PALAZZINI, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 4.277
EU - Europa 3.040
AS - Asia 1.771
AF - Africa 260
SA - Sud America 19
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.378
Nazione #
US - Stati Uniti d'America 4.258
IT - Italia 764
GB - Regno Unito 749
CN - Cina 583
SG - Singapore 488
VN - Vietnam 414
DE - Germania 362
SE - Svezia 282
UA - Ucraina 203
IE - Irlanda 178
RU - Federazione Russa 155
IN - India 151
FR - Francia 122
CI - Costa d'Avorio 98
TG - Togo 72
ZA - Sudafrica 63
EE - Estonia 59
JO - Giordania 48
BG - Bulgaria 31
FI - Finlandia 29
NL - Olanda 25
BE - Belgio 21
CA - Canada 19
BR - Brasile 18
CH - Svizzera 17
IR - Iran 17
ID - Indonesia 12
JP - Giappone 12
SC - Seychelles 12
AT - Austria 11
NG - Nigeria 11
TR - Turchia 8
AU - Australia 7
HK - Hong Kong 7
PK - Pakistan 7
GR - Grecia 5
KR - Corea 5
PH - Filippine 5
PL - Polonia 5
LB - Libano 4
LT - Lituania 4
CZ - Repubblica Ceca 3
EG - Egitto 3
HR - Croazia 3
MK - Macedonia 3
AL - Albania 2
BD - Bangladesh 2
MY - Malesia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
HU - Ungheria 1
KE - Kenya 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
TH - Thailandia 1
Totale 9.378
Città #
Southend 677
Chandler 513
Fairfield 501
Singapore 389
Ashburn 313
Santa Clara 265
Wilmington 246
Woodbridge 240
Dong Ket 197
Houston 188
Princeton 180
Seattle 180
Dublin 178
Cambridge 172
Ann Arbor 156
Bologna 121
Boardman 112
Abidjan 98
Jacksonville 93
Padova 77
Nanjing 74
Westminster 74
Lomé 72
Milan 68
Turin 61
Beijing 53
Berlin 50
Amman 48
Jinan 39
Shenyang 38
San Diego 33
Medford 29
Saint Petersburg 29
Sofia 29
Hebei 27
Helsinki 27
Jiaxing 26
Guangzhou 24
Nanchang 22
Brussels 21
Changsha 20
Des Moines 20
Rome 20
Mülheim 18
Dearborn 16
Shanghai 16
Yubileyny 16
Falls Church 15
Florence 14
Hangzhou 14
Olalla 14
Zhengzhou 13
Amsterdam 12
Falkenstein 12
Jakarta 12
Los Angeles 12
Redmond 12
Tianjin 12
Abeokuta 11
Bern 11
Mahé 11
New York 11
Taizhou 11
Bremen 10
London 10
Ningbo 10
Monmouth Junction 9
Norwalk 9
Redwood City 9
Tokyo 9
Toronto 9
Vienna 9
Ardabil 8
Cernusco sul Naviglio 8
Chengdu 8
Genoa 8
Nuremberg 8
Paris 8
Perugia 8
Bühl 7
Haikou 7
Moscow 7
Napoli 7
Palermo 7
Reggio Emilia 7
Shenzhen 7
Taiyuan 7
Andover 6
Beauharnois 6
Buffalo 6
Dongguan 6
Hong Kong 6
Kunming 6
Phoenix 6
Verona 6
Karachi 5
Naples 5
San Pablo City 5
Xi'an 5
Zanjan 5
Totale 6.332
Nome #
A new CT-score as index of hemodynamic changes in patients with chronic thromboembolic pulmonary hypertension 210
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 195
Complicanze del cateterismo cardiaco destro in pazienti con ipertensione polmonare precapillare di grado severo. 176
Il test acuto di vasoreattività nei pazienti con ipertensione arteriosa polmonare. 173
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension 173
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: Real-world insights 167
Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients 165
A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension 163
Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease 159
Pulmonary Arterial Hypertension associated to connective tissue diseases 154
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 151
Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration 147
Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes 144
Genere femminile e ipertensione arteriosa polmonare: una relazione complessa Female gender and pulmonary arterial hypertension: a complex relationship 139
Andamento clinico, emodinamico e dei livelli plasmatici dell’NT-pro BNP in pazienti con ipertensione polmonare precapillare 137
BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis 137
Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy? 132
Anticoagulant treatment in patients with pulmonary arterial hypertension associated with systemic sclerosis: More shadows than lights 132
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. 131
Challenges in pulmonary hypertension: Managing the unexpected 130
Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension 130
Current therapeutic approaches to pulmonary arterial hypertension. 128
Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare. 127
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. 124
Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension. 121
Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study 120
Effetti clinici ed emodinamici del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare. 114
Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. 114
Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida. 113
Rare causes of pulmonary hypertension. Spectrum of radiological findings and review of the literature 113
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism 113
The difficult diagnosis of pulmonary vascular disease in heart failure 112
Effetti del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare idiopatica, associata e cuore polmonare cronico tromboembolico. 111
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome. 111
Sildenafil therapy in patients with porto-pulmonary hypertension 110
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 110
Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease 109
Confronto tra antagonista recettoriali selettivi e non selettivi dell'endotelina nel trattamento dell'ipertensione arteriosa polmonare. 107
Cardiologia pediatrica. Problematiche cliniche 107
Effetti emodinamici e funzionali dell'epoprostenolo in associazione agli antagonisti recettoriali dell'endotelina e agli inibitori delle fosfodiesterasi-5 106
Pulmonary hypertension and systemic sclerosis: the role of highresolution computed tomography. 106
Long-term therapeutic outcomes in pulmonary arterial hypertension 105
Pulmonary veno-occlusive disease: the role of CT 105
Pulmonary arterial hypertension. Part II: Medical and surgical treatment 104
Exercise training in pulmonary hypertension: improving performance but waiting for outcome 104
Effetti del sildenafil in soggetti con cuore polmonare cronico tromboembolico 102
Pharmacological impact on right ventricular remodelling in pulmonary arterial hypertension 101
A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines 101
Current medical therapies in pulmonary arterial hypertension 100
Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects 100
Effetti a lungo termine del trattamento con bosentan sulla capacità funzionale e sui parametri emodinamici nei pazienti con ipertensione arteriosa polmonare. 99
Evidence for Kaposi's sarcoma-associated herpes virus infection in patients with idiopathic pulmonary arterial hypertension: a case series and review of the literature 98
GPs meet rare lung disorders task force factsheet: Pulmonary arterial hypertension 97
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 97
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 95
Left ventricular dimensions in pulmonary arterial hypertension: haemodynamic and exercise correlations 94
Pulmonary vascular disease due to left heart disease: How to achieve a more accurate approach beyond the haemodynamic phenotype: Reply 94
Conventional Medical Therapies in the treatment of pulmonary hypertension 93
L. Negro, M. Zavatta, C. Bachetti, E. Beciani, M. Palazzini, S. Romanazzi, E. Leci, M. Grossi, A. Marinelli, S. Gambetti, A. Manes, N. Galiè, A. Branzi 93
Pulmonary hypertension due to left heart disease 93
Pulmonary hypertension 92
[Treatment goals of pulmonary hypertension]. 90
Effetti a lungo termine del trattamento con sildenafil nei pazienti affetti da ipertensione arteriosa polmonare associata a cardiopatie congenite con shunt 89
Reverse remodelling of ECG changes in idiopathic pulmonary arterial hypertension patients responders to chronic treatment with calcium channel blockers 89
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension 88
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed. 87
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. 87
The burden of comorbidities in pulmonary arterial hypertension 86
Long-term efficacy and safety of sildenafil in precapillary pulmonary hypertension 85
Left Main Coronary Artery Extrinsic Compression in Patients With Pulmonary Arterial Hypertension: Technical Insights and Long-Term Clinical Outcomes After Stenting 85
Epidemiology of patients referred to a specialised pulmonary hypertension center 83
Treatment goals of pulmonary hypertension. 81
Experience with inheritable pulmonary arterial hypertension in a specialised center 81
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry 79
Ipertensione polmonare: Necessità di chiarezza tra definizione emodinamica-fisiopatologica, stima ecocardiografica e diagnosi clinica finale. Pulmonary hypertension and the relationships between hemodynamic-pathophysiologic definitions, echocardiographic estimate and final clinical diagnosis: clarification is needed. 78
Pulmonary artery intimal sarcoma. Problems in the differential diagnosis. I sarcomi intimali dell'arteria polmonare. Problemi di diagnosi differenziale 78
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial 78
Thrombolysis in high-risk patients with acute pulmonary embolism: underuse of a life-saving treatment in the real-world setting 76
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism 74
Extracorporeal cardiopulmonary support in acute high-risk pulmonary embolism: Still waiting for solid evidence 70
Pulmonary arterial hypertension: Guidelines and unmet clinical needs 66
Balloon pulmonary angioplasty after pulmonary thromboendarterectomy 65
Pulmonary Hypertension: Lessons from Adults 63
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial 56
Long-term outcomes after pulmonary endarterectomy 53
Progressi nel trattamento delle malattie della circolazione polmonare 46
Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools 42
Chronic thromboembolic pulmonary disease 26
Chronic Thromboembolic Pulmonary Hypertension and Chronic ThromboembolicPulmonary Disease (CTEPD): Clinical and Interventional Perspective 24
Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors 23
Metrics for Success of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension 18
Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: a single centre real-world experience 18
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function 17
Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds 16
Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease 13
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2 13
Extrinsic Compression Of The Left Main Coronary Artery By Enlarged Pulmonary Artery In Patients With Pulmonary Arterial Hypertension 13
Left main coronary artery extrinsic compression by enlarged pulmonary artery in patients with pulmonary arterial hypertension 12
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension 9
Totale 9.645
Categoria #
all - tutte 26.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020617 0 0 0 0 0 0 0 0 279 151 88 99
2020/20211.267 217 71 32 60 27 100 24 58 121 54 47 456
2021/20221.603 139 80 106 134 123 88 43 100 62 118 303 307
2022/20232.045 202 275 94 266 94 171 62 115 416 96 146 108
2023/2024411 36 78 30 43 29 56 23 12 12 33 34 25
2024/20251.679 79 384 259 162 396 105 166 89 39 0 0 0
Totale 9.645